Overview

Reduced Intensity Conditioning (RIC) Regimen and Post-transplant Cyclophosphamide in Haploidentical Bone Marrow Transplantation in in Patients With Poor Prognosis Lymphomas

Status:
Unknown status

Trial end date:
2016-11-01

Target enrollment:

Participant gender:

Summary

Study to test feasibility and efficacy of T-replete Bone Marrow (BM), infused after a RIC regimen and post-transplantation Cyclophosphamide (Cy), in patients with poor prognosis lymphomas.

Phase:

Phase 2

Details

Lead Sponsor:

Istituto Clinico Humanitas

Treatments:

Cyclophosphamide
Fludarabine
Fludarabine phosphate
Thiotepa